
1:1 Consultation
A focused 45-minute private consultation with a MORROW doctor following your group discussion. This session reviews your results in the context of your health history and risk profile, helping identify priority areas and outline clear next steps for monitoring, lifestyle optimisation, or specialist referral where appropriate.
$199

$499
View the full panels
CEA
Carcinoembryonic antigen is a protein that may rise in colorectal and other cancers. While not diagnostic on its own due to elevations from smoking or inflammation, a baseline CEA allows meaningful trend tracking over time. Rising levels warrant evaluation and are particularly useful for detecting recurrence or monitoring treatment response in individuals with known cancer history.
AFP
Alpha-fetoprotein is a protein used primarily for liver cancer surveillance, especially in individuals with hepatitis, cirrhosis, or chronic liver disease. Rising AFP levels may signal changes in liver health that warrant closer monitoring or follow-up. Baseline measurement enables longitudinal monitoring, with elevated levels warranting further assessment.
CA 19-9
CA 19-9 is most closely associated with pancreatic and biliary cancers. Although unsuitable for routine screening, it provides valuable baseline data and aids early investigation when levels rise over time, particularly in those with symptoms or family history. It is also useful for monitoring treatment response in individuals with diagnosed disease.
PSA (total and free) – males only
Prostate-specific antigen is the standard blood marker for prostate cancer screening. Total PSA may rise in benign or malignant conditions, while the free-to-total PSA ratio improves risk assessment, with lower ratios suggesting higher cancer risk. Monitoring PSA trends is especially informative, as rapid increases may signal concern even at modest absolute levels. Your physician will interpret your results in the context of your age, symptoms, and risk factors.
CA 125 – females only
CA 125 is associated with ovarian cancer but can also rise in benign gynecological conditions. It is most useful when combined with symptoms and pelvic imaging, as ovarian cancer is difficult to detect early. Establishing a baseline supports trend monitoring, with rising values prompting further evaluation.
EBV and FIT - both genders
The EBV (Epstein–Barr Virus) blood test helps assess risk related to certain virus-associated cancers, including nasopharyngeal cancer, which is more prevalent in parts of Asia. The FIT (Faecal Immunochemical Test) screens for hidden blood in the stool — an early sign of colorectal cancer. Both tests are simple, non-invasive tools that support early detection before symptoms appear.
Gender-specific markers (PSA/CA-125)
PSA (Prostate-Specific Antigen) is a blood marker used in men to assess prostate health and detect early changes that may require further evaluation. CA-125 is a blood marker used in women to monitor ovarian health, particularly in those with symptoms or higher risk profiles. These markers are interpreted within clinical context and used to guide appropriate follow-up where needed.
Multi-cancer early detection (Optional)

SPOT-MAS™ test
$899
For more comprehensive screening, add SPOT-MAS to your panel. This multi-cancer early detection test uses advanced circulating tumour DNA (ctDNA) analysis to screen for 10 common cancer types, often before any symptoms appear. It provides an additional layer of vigilance, helping you catch potential risks sooner. Ideal for those seeking proactive, broader surveillance beyond traditional markers.

LucenceINSIGHT™ 50 test
$3,999
For the most extensive insight into your health, upgrade to Lucence MCED (Multi-Cancer Early Detection). As our most advanced screening solution, this single blood test expands your coverage to over 50 different types of cancer. By providing the widest possible net for early detection, Lucence MCED offers the ultimate peace of mind for you and your family. Recommended for individuals with a family history of cancer or those who want the most thorough screening available.
Disclaimer: Tumour markers and MCED tests are not diagnostic for cancer and are not recommended for general population screening. Elevated levels may be caused by non-cancerous conditions such as inflammation, infection, or benign growths. Similarly, normal results do not exclude the presence of cancer. This panel establishes baseline values for longitudinal monitoring and should not replace age-appropriate cancer screening (such as colonoscopy, mammography, or other recommended tests). These results must be interpreted alongside clinical findings and other investigations by your physician.

$499
View the full panels
NT-proBNP
N-terminal pro-B-type natriuretic peptide is a hormone released when the heart muscle is under strain. Elevated levels signal early cardiac stress from conditions such as high blood pressure, valve disease, or developing heart failure—often long before symptoms like breathlessness or fatigue appear. NT-proBNP offers early clarity on how the heart is responding to strain, helping guide timely lifestyle or care adjustments and track changes over time.
Homocysteine
Homocysteine is an amino acid produced during protein metabolism that can damage blood vessel walls when elevated. High levels are independently linked to heart attack, stroke, peripheral artery disease, and dementia, driven by vascular inflammation and plaque formation. Homocysteine also reflects functional status of key B vitamins—B12, folate, and B6—and is highly actionable, as levels often improve with targeted nutritional intervention, making it valuable for cardiovascular and brain risk optimisation.
ApoA1
Apolipoprotein A1 is the main structural protein of HDL particles responsible for removing cholesterol from artery walls and transporting it back to the liver. Measuring ApoA1 reflects the number and effectiveness of protective HDL particles rather than cholesterol content alone, which can be misleading. Higher levels are associated with stronger cardiovascular protection, while lower levels indicate impaired cholesterol clearance even when HDL cholesterol appears normal.
ApoB/ApoA1 ratio
Apolipoprotein B/Apolipoprotein A1 ratio represents the balance between atherogenic particles and protective HDL particles in a single, powerful metric. It captures net cardiovascular risk more accurately than traditional cholesterol ratios, showing whether harmful particles outweigh the body's ability to clear them. Lower ratios indicate favourable lipid balance and reduced cardiovascular risk, while higher ratios signal the need for intervention.
Lp(a)
Lipoprotein(a), or lipoprotein little a, is a genetically determined LDL-like particle with an added protein that promotes inflammation and clot formation. Levels are largely fixed for life and minimally influenced by lifestyle, yet significantly increase risk of heart attack, stroke, and aortic valve disease. Testing Lp(a) enables lifetime risk stratification and identifies individuals who benefit from more aggressive management of all modifiable cardiovascular risk factors. Elevated levels warrant enhanced prevention efforts.

$499
View the full panels
TSH
Thyroid stimulating hormone regulates thyroid hormone production and is the primary marker of thyroid function. Thyroid hormones are critical for brain metabolism, neurotransmitter balance, and cognitive speed, making subtle dysfunction clinically meaningful. Elevated TSH suggests underactive thyroid activity linked to brain fog and low mood, while low TSH reflects overactivity associated with anxiety and impaired focus. For cognitive optimisation, TSH is best maintained within a tighter range than standard reference values, which your physician will determine based on your symptoms and overall thyroid profile.
FT4
Free thyroxine represents the circulating reserve of thyroid hormone produced by the thyroid gland. Adequate FT4 is necessary to supply sufficient substrate for conversion into active T3, supporting brain energy and mental clarity. Low or low-normal FT4 can contribute to cognitive symptoms even when TSH appears normal. FT4 helps assess thyroid production capacity, with optimal cognitive support typically seen in the mid-to-upper reference range.
FT3
Free triiodothyronine is the active thyroid hormone that directly drives brain and cellular metabolism. Impaired conversion from T4 to T3—often due to stress, inflammation, or nutrient deficiencies—can result in brain fog and mental fatigue despite normal TSH and FT4. Measuring FT3 identifies activation issues missed by standard screening and is key for cognitive optimisation, with best function generally in the mid-to-upper reference range.
Homocysteine
Homocysteine is an amino acid that when elevated can damage blood vessel walls and is independently linked to cognitive decline, dementia risk, and vascular damage to the brain. High levels reflect impaired B-vitamin metabolism (B12, folate, B6) and contribute to vascular inflammation affecting brain health. Homocysteine is highly actionable—levels often improve with targeted nutritional intervention. For brain health optimisation, lower levels support better vascular integrity and reduced dementia risk.
Cognitive assessment
A standardised cognitive assessment establishes your baseline cognitive performance across key domains including memory, attention, processing speed, and executive function. This baseline enables meaningful tracking over time, helping distinguish normal age-related changes from early cognitive decline. Regular assessment allows for earlier intervention if changes are detected, and provides objective data to guide lifestyle modifications aimed at maintaining cognitive health.

$899
View the full panels
CK
Creatine kinase is an enzyme released when muscle tissue breaks down and reflects the balance between training load and recovery. Temporary elevation after intense exercise is normal and indicates adaptation, but persistently high levels suggest inadequate recovery, overtraining, or increased injury risk. Significantly elevated CK may signal rhabdomyolysis, muscle disease, or medication side effects. Tracking CK helps athletes optimise training intensity, recovery strategies, and prevent overtraining. Markedly elevated or persistently high levels warrant medical evaluation.
Homocysteine
Homocysteine is an amino acid that rises with impaired B-vitamin metabolism and contributes to vascular inflammation and oxidative stress. In athletes, elevated homocysteine reflects reduced methylation capacity, which can impair recovery, energy production, and training adaptation. Optimising homocysteine through B12, folate, and B6 support improves vascular health, reduces inflammation, and enhances recovery. Lower levels are associated with better cardiovascular health and training adaptation.
ApoB
Apolipoprotein B represents the number of atherogenic lipid particles circulating in the blood and is the most accurate marker of cardiovascular risk. High fitness does not offset elevated ApoB, making it essential for athletes placing sustained stress on the heart. ApoB identifies hidden risk even when LDL cholesterol appears normal and guides long-term cardiovascular optimisation for athletic longevity.
ApoA1
Free triiodothyronine is the active thyroid hormone that directly drives brain and cellular metabolism. Impaired conversion from T4 to T3—often due to stress, inflammation, or nutrient deficiencies—can result in brain fog and mental fatigue despite normal TSH and FT4. Measuring FT3 identifies activation issues missed by standard screening and is key for cognitive optimisation, with best function generally in the mid-to-upper reference range.
ApoB/ApoA1 ratio
The ApoB/ApoA1 ratio captures the balance between harmful and protective lipid particles and is one of the strongest predictors of cardiovascular risk. Even physically fit individuals may have unfavourable ratios, signalling risk despite regular exercise. Lower ratios support long-term cardiovascular resilience alongside performance.
Lp(a)
Lipoprotein(a) is a genetically determined lipid particle that increases cardiovascular risk regardless of fitness, diet, or training. Elevated Lp(a) requires aggressive optimisation of all modifiable risk factors to offset inherited risk. As levels remain stable throughout life, this test provides critical lifetime risk stratification for longevity planning in athletic populations.
Total testosterone
Total testosterone is the primary androgen supporting muscle mass, strength, recovery, energy, motivation, and vitality. Low levels impair performance, body composition, recovery, and cognitive drive, while overtraining, stress, poor sleep, and ageing accelerate decline. For performance optimisation, testosterone is best maintained in the mid-to-upper reference range rather than merely "normal." Morning testing provides the most accurate baseline.
Free testosterone
Free testosterone represents the biologically active fraction available to tissues and is often a better indicator of androgen status than total testosterone. High SHBG can lower free testosterone despite normal total levels, leading to fatigue, poor recovery, and reduced strength gains. Measuring free testosterone ensures accurate assessment of hormonal support for performance and vitality, particularly when symptoms do not match total testosterone values.
SHBG
Sex hormone binding globulin regulates how much testosterone is bioavailable by binding circulating hormones. High SHBG reduces free testosterone despite normal total levels, while low SHBG may indicate metabolic dysfunction. For athletes, SHBG provides essential context for interpreting testosterone results and guides whether optimisation should focus on lifestyle, metabolic health, or direct hormonal intervention.
IGF-1
Insulin-like growth factor 1 reflects growth hormone activity and anabolic capacity, supporting muscle growth, tissue repair, bone density, and recovery. Low IGF-1 may indicate inadequate recovery, overtraining, poor nutrition, or age-related decline. Mid-to-upper reference range levels suggest strong adaptive and recovery potential, while notably low levels warrant further evaluation.
TSH
Thyroid stimulating hormone regulates thyroid hormone production and is central to metabolic rate, energy output, heart function, and recovery. Even mild thyroid dysfunction can impair performance, endurance, and training adaptation. For athletes, optimal TSH falls within a narrower range than standard laboratory references, with your physician determining appropriate targets based on your training demands and symptoms.
FT4
Free thyroxine reflects thyroid hormone production capacity and supplies the substrate for conversion to active T3. Low or low-normal FT4 can contribute to fatigue and impaired recovery even when TSH appears normal. For performance optimisation, FT4 is ideally maintained in the mid-to-upper reference range and is essential for complete thyroid assessment.
Zinc (serum)
Zinc is essential for immune function, testosterone production, protein synthesis, and recovery. Athletes commonly develop deficiency due to increased losses through sweat and urine, leading to frequent infections, reduced hormonal output, and slower recovery. Testing zinc status guides targeted supplementation to support immunity, performance, and training adaptation.
Selenium (serum)
Selenium is a trace mineral required for antioxidant defence and thyroid hormone conversion from T4 to active T3. Deficiency increases oxidative stress, weakens immunity, and impairs thyroid efficiency—particularly relevant for athletes under high training load. Testing identifies individuals who benefit from supplementation to support thyroid optimisation and recovery capacity.
1Notes on interpretation
Important: Individual biomarker results should always be interpreted in the context of your complete health profile, family history, symptoms, and other test results. Optimal ranges vary based on individual risk factors, training status, and health goals. These markers are screening tools that may prompt further investigation—they are not diagnostics on their own.
For optimal use: Your physician will review these results during your consultation and create a personalised health optimisation or disease prevention plan based on your unique risk profile and health goals.

A comprehensive screening panel for health-conscious individuals who want to identify hidden cardiovascular, metabolic, and cancer risks before symptoms appear. This bundle combines advanced lipid analysis, multi-cancer early detection, and foundational metabolic screening to reveal risks that standard panels miss.

Prevention and Peak Function
Complete preventive and performance panel
Includes 1:1 doctor consultation
$1,799
Designed for individuals who want to detect health risks early while optimising performance and resilience, this screening package provides a comprehensive, doctor-led assessment of how your body is functioning beneath the surface.
It focuses on early identification of cardiometabolic, hormonal, inflammatory, and recovery-related imbalances-before they become symptoms or disease, while also helping guide smarter training, better recovery, and sustainable performance.
This is a comprehensive prevention and optimisation panel integrating advanced biomarkers across:
Hormonal balance
Metabolic health
Cardiovascular risk and resilience
Inflammation and immune stress
Recovery capacity and physiological load
The goal: stay ahead of disease, extend healthspan, and perform well without burning out.